Studying mitral valve repair for atrial regurgitation
Part of Heart & circulation clinical trials.
This trial tests a minimally invasive procedure (transcatheter edge-to-edge repair) to fix a leaky mitral valve caused by an enlarged atrium, not by heart muscle damage. It might be an option if your mitral regurgitation is related to atrial issues and your heart's pumping strength is normal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have mitral regurgitation caused by functional/atrial factors (not structural valve damage).
- Your left ventricle's pumping ability (ejection fraction) is at least 50%.
- You are 18 years or older.
- You do not have known wall movement abnormalities in your heart.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a procedure that combines two treatments: fixing a leaky heart valve (mitral regurgitation) and treating an irregular heartbeat (atrial fibrillation) at the same time. It aims to improve symptoms and heart function in people with both conditions.
This trial tests a minimally invasive procedure to repair a leaky mitral valve in people with a specific type of heart failure. The goal is to see if the procedure, called transcatheter edge-to-edge repair (TEER), is safe and effective in reducing symptoms and improving heart function.
This study tests a minimally invasive procedure (edge-to-edge repair) for people whose mitral valve leaks because of an enlarged upper heart chamber (atrial functional mitral regurgitation). The goal is to see if this clip repair improves symptoms and outcomes compared with standard medical therapy alone.
This study is gathering information from people getting a less invasive procedure called M-TEER to fix a leaky mitral valve. Joining helps doctors learn more about how this treatment works in real life.
This trial tests a new way to repair a leaky mitral valve without stopping the heart or using a heart-lung machine. The surgery is done through a small cut in the heart's lower chamber. It may be an option for people with severe degenerative mitral regurgitation who are not good candidates for standard open-heart surgery.
This trial tests a new catheter-based device to fix a leaky mitral valve without open-heart surgery. It is for people whose severe mitral regurgitation puts them at high risk for traditional surgery.
Hear when a new Atrial Functional Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.